Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
Oct 21 (Reuters) - Bone Biologics Corp BBLG.O:
BONE BIOLOGICS APPOINTS PHILLIP T. MEIKLE TO ITS BOARD OF DIRECTORS
BONE BIOLOGICS CORP - NUMBER OF DIRECTORS AT BONE BIOLOGICS REMAINS AT FOUR
Source text for Eikon: (Full Story)
Further company coverage: BBLG.O
U.S. stocks traded mixed this morning, with the Dow Jones jumping over 200 points on Monday.
Following the market opening Monday, the Dow traded up 0.54% to 41,618.01 while the NASDAQ fell 0.69% to 17,562.23. The S&P 500 also fell, dropping, 0.06% to 5,622.81.
Check This Out: This Analyst With 86% Accuracy Rate Sees Around 9% Upside In RH – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts
Leading and Lagging Sectors
Energy shares jumped by 1.7% on Monday.
In trading on Monday, information technology shares fell by 1.4%.
Top Headline
The NY Empire State Manufacturing Index rose to 11.5 in September, recording the highest level since April 2022, versus -4.7 in August and market estimates of -3.9.
Equities Trading UP
Equities Trading DOWN
Commodities
In commodity news, oil traded up 1.4% to $69.59 while gold traded down 0.1% at $2,608.10.
Silver traded up 0.7% to $31.28 on Monday, while copper rose 0.6% to $4.2630.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.1%, Germany's DAX fell 0.3% and France's CAC 40 fell 0.2%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 fell 0.02%.
The Eurozone recorded a trade surplus of EUR 21.2 billion in July, higher than market estimates of EUR 14.9 billion. Wages in the Eurozone increased 4.5% year-over-year in the second quarter, while hourly labor costs climbed by 4.7% year-over-year in the quarter. Italy reported a trade surplus of EUR 6.743 billion in July versus a year-ago surplus of EUR 6.108 billion.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Hong Kong's Hang Seng Index gaining 0.31% and India's BSE Sensex gaining 0.12%.
Total passenger vehicle sales in India declined 1.6% year-over-year to 308,779 in August versus a 1.9% decline in the prior month.
Economics
The NY Empire State Manufacturing Index rose to 11.5 in September, recording the highest level since April 2022, versus -4.7 in August and market estimates of -3.9.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Bone Biologics just reported results for the second quarter of 2024.
InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.
More from InvestorPlace
Bone Biologics Corp BBLG.OQ reported a quarterly adjusted loss of 67 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $-3.84. The lone analyst forecast for the quarter was for a loss of $1.39 per share.
Reported revenue was zero; analysts expected zero.
Bone Biologics Corp's reported EPS for the quarter was a loss of 67 cents.
The company reported a quarterly loss of $783 thousand.
Bone Biologics Corp shares had risen by 30.3% this quarter and lost 64.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 81.5% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
Wall Street's median 12-month price target for Bone Biologics Corp is $19.50
This summary was machine generated from LSEG data August 9 at 10:14 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2024 | -1.39 | -0.67 | Beat |
Mar. 31 2024 | -7.60 | -1.31 | Beat |
Dec. 31 2023 | -5.60 | -2.47 | Beat |
Sep. 30 2023 | -24.32 | -4.88 | Beat |
Keywords: BONE BIOLOGICS-RESULTS/SUMMARY
We have all of the biggest pre-market stock movers that traders need to know about on Friday morning!
Moving stocks this morning and more earnings reports, an acquisition deal, liquidation news and more.
Let’s get into that news below!
Biggest Pre-Market Stock Movers: 10 Top Gainers
10 Top Losers
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More from InvestorPlace
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 1% on Thursday.
The Dow traded up 0.03% to 40,853.73 while the NASDAQ rose 0.96% to 17,768.43. The S&P 500 also rose, gaining, 0.62% to 5,556.62.
Leading and Lagging Sectors
Communication services shares jumped by 3.4% on Friday.
In trading on Friday, energy shares fell by 0.8%.
Top Headline
Meta Platforms, Inc. reported better-than-expected second-quarter financial results and issued strong third-quarter guidance.
Meta reported second-quarter revenue of $39.07 billion, beating analyst estimates of $38.31 billion. The company reported second-quarter adjusted earnings of $5.16 per share, beating analyst estimates of $4.73 per share.
Equities Trading UP
Equities Trading DOWN
Commodities
In commodity news, oil traded up 0.6% to $78.37 while gold traded up 1% at $2,497.80.
Silver traded up 0.7% to $29.125 on Thursday, while copper fell 0.5% to $4.1545.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX fell 1.1% and France's CAC 40 fell 1.3%. Spain's IBEX 35 Index fell 0.7%, while London's FTSE 100 rose 0.2%.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 dipping 2.49%, Hong Kong's Hang Seng Index falling 0.23% and S&P BSE Sensex gaining 0.15%.
Economics
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.